Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q83392197)
Watch
English
Development of targeted therapies for pancreatic cancer
scientific article published on 01 March 2011
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
21306954
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21306954%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 January 2020
title
Development of targeted therapies for pancreatic cancer
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
21306954
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21306954%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 January 2020
main subject
pancreatic cancer
1 reference
based on heuristic
inferred from title
author name string
Philip A Philip
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
21306954
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21306954%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 January 2020
publication date
1 March 2011
1 reference
stated in
Europe PubMed Central
PubMed ID
21306954
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21306954%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 January 2020
published in
Lancet Oncology Commission
1 reference
stated in
Europe PubMed Central
PubMed ID
21306954
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21306954%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 January 2020
volume
12
1 reference
stated in
Europe PubMed Central
PubMed ID
21306954
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21306954%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 January 2020
issue
3
1 reference
stated in
Europe PubMed Central
PubMed ID
21306954
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21306954%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 January 2020
page(s)
206-207
1 reference
stated in
Europe PubMed Central
PubMed ID
21306954
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21306954%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 January 2020
cites work
Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the Cancer and Leukemia Group B (CALGB 80303).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970029-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase III trial of bevacizumab in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970029-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970029-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970029-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Novel targets for pancreatic cancer therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970029-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Consensus report of the national cancer institute clinical trials planning meeting on pancreas cancer treatment.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970029-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy of gemcitabine plus axitinib compared with gemcitabine alone in patients with advanced pancreatic cancer: an open-label randomised phase II study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970029-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S1470-2045(11)70029-8
1 reference
stated in
Europe PubMed Central
PubMed ID
21306954
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21306954%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 January 2020
PubMed ID
21306954
1 reference
stated in
Europe PubMed Central
PubMed ID
21306954
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21306954%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 January 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
